Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-21-006714
Filing Date
2021-03-24
Accepted
2021-03-24 16:15:32
Documents
3

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 525519
2 form424b5_001.jpg GRAPHIC 19826
3 form424b5_002.jpg GRAPHIC 15720
  Complete submission text file 0001493152-21-006714.txt   575850
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 424B5 | Act: 33 | File No.: 333-232067 | Film No.: 21768378
SIC: 2834 Pharmaceutical Preparations